BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc.（BBOT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bbot · 股价预测 · 3 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 3 位华尔街分析师
Buy
3 位分析师
共识
评级分布
12 个月目标价
High
$24.00
Consensus
$22.00
+182.8% upside
Low
$18.00
Median: $23 · Last Close: $7.78
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$22.00
182.8% upside
High Target
$24
208.5%
Low Target
$18
131.4%
Current Price
$7.78
as of today
Based on analyst price targets, the BBOT stock price prediction for the next 12 months ranges from $18 to $24. The consensus BBOT price forecast of $22.00 implies 182.8% upside from the current price of $7.78.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.54 | ↓ 3.13% |
1-day model range: $7.49–$7.58. Peak: $7.58 (-3.13%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $7 | -16.5% |
| 2028 | $6 | -24.0% |
| 2029 | $6 | -27.8% |
| 2030 | $5 | -29.8% |
| 2031 | — | -30.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BBOT · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-11 | Wedbush | Maintains | Outperform→Outperform |
| 2025-11-25 | Wedbush | Maintains | Outperform→Outperform |
| 2025-11-13 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on BridgeBio Oncology Therapeutics Inc. (BBOT) stock. Of the recent 4 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover BBOT.
分析师推荐趋势
BBOT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$29M
EPS This Year
$-2.24
EPS Next Year
$-2.14
↓ 4.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast BBOT EPS of $-2.24 for the current fiscal year, based on estimates from 6 analysts. The BBOT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BBOT 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BBOT 的共识目标价为 $22.00（+182.8% 上行空间），分析师共识为 Buy。
BBOT 的短期预测（明日）为 $7.54（-3.13%）。 BBOT 对 2027 年的股价预测均值为 $7。 BBOT 对 2030 年的预测区间为 $5–$6。
BridgeBio Oncology Therapeutics Inc. 在 NASDAQ 上市，代码 BBOT。BBOT 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
BBOT 预测 · 8 个问题根据 3 位华尔街分析师，BBOT 的 12 个月平均目标价为 $22.00，最高 $24.00、最低 $18.00。若有图表，中位目标价可在上方查看。相对当前价 $7.78，隐含约 +182.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.